clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Advanced Ovarian Cancer Regimen Plus Personalized Vaccine Doubles Survival Time
Coronavirus
Cough Sounds Predict Pneumonia Risk in Early COVID-19
News & Features
Scientists Improve Anti-Tumor Power of CAR-T Cells
News & Features
Depression and Frailty Share Genetics
News & Features
Premenstrual Food Cravings Linked with Insulin Sensitivity
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Authors
Posts by Jeffrey S. Buguliskis, Ph.D.
Jeffrey S. Buguliskis, Ph.D.
34 POSTS
0 COMMENTS
Ph.D. Technical Editor
News & Features
Genomics Brings Heavy Lifting to Immuno-Oncology
March 21, 2017
Molecular Dx
Infectious Fight: Tackling the Inevitability of Resistance, One Genome at...
February 7, 2017
Molecular Dx
Commonplace Sequencing Makes Disease Less Rare
November 1, 2016
News & Features
Marking the Sweet Spot for Immunotherapies
September 7, 2016
Molecular Dx
Maximum Resolution Requires Maximum Depth for Next-Gen Sequencing
August 1, 2016
Molecular Dx
Breathing New Life into Cystic Fibrosis Genetic Testing
July 4, 2016
Molecular Dx
Pharmacogenomics Makes the Heart Grow Stronger
June 1, 2016
Molecular Dx
The Epigenetic Insights of RNA-Seq
May 2, 2016
Molecular Dx
The Potential of Precision Medicine Rests in Bringing Molecular Diagnostics to...
March 31, 2016
Molecular Dx
PCR Has a History of Amplifying Its Game
March 1, 2016
1
2
3
4
Page 2 of 4
Related Content
Moderna and Immatics Ink Potential $1.7B Multi-Omic Cancer Deal
“Inverse Vaccine” Could Treat Multiple Sclerosis and Range of Other Autoimmune Diseases
Lung Cell Therapy Shows Promise for Treating COPD
Designer Peptide Targeting Protein-Protein Interaction Could Become Glioblastoma Treatment
Inside Precision Medicine
![Bringing molecular diagnostics to market is an arduous process dotted with regulatory issues and decisions affecting the long term future of the product. Yet it is a critical part of fostering the possibilities within precision medicine. [iStock / KEXINO]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/583-324x160.jpeg "The Potential of Precision Medicine Rests in Bringing Molecular Diagnostics to Market")
